LONG TERM OUTCOMES OF RESTOR IOL IMPLANTATION Lori Dao, Orkun Muftuoglu, V. Vinod Mootha, Steven M. Verity, R. Wayne Bowman, H. Dwight Cavanagh, James.

Slides:



Advertisements
Similar presentations
Comparison of Visual Outcomes With Toric IOL and With Limbal Relaxing Incisions in Cataract Surgery Eriko Fukuyama, MD Fukuyama Eye Clinic Fukuoka, Japan.
Advertisements

Clinical Outcomes after Presbyopic Correcting Intraocular Lens Surgery in Patients with Prior Keratorefractive Surgery at UTSW Medical Center: A Retrospective.
Comparison of surgically induced astigmatism after phacoemulsification trough 3.2, 2.2 and 1.8 clear corneal incision. Luis Izquierdo Jr MD. PhD. Maria.
Keiichiro Minami, Hiroko Bissen-Miyajima, Mami Yoshino, Kunihiko Nakamura Department of Ophthalmology Tokyo Dental College Suidobashi Hospital, Tokyo,
Long-Term Follow-Up of Toric Intraocular Lens Implantation for Keratoconus Alejandro Navas, MD, MSc, Martha Jaimes, MD, Jesús Cabral, MD, Arturo Ramirez.
In-the-Bag Toric IOL for Correction of Astigmatism in Keratoconus and after Corneal Surgery Bart T.H. van Dooren, M.D., Ph.D Ilse E.M.A. Mol, M.D. Department.
Visual outcome & subjective visual symptoms of the Tecnis ZM900 multifocal intraocular lens in Asian eyes Dr Colin S.H. Tan MBBS, MMed (Ophth), FRCSEd.
Anupama Kotha 1, Simar J. Singh 1, William B. Trattler 1,2, Carlos Buznego 1,2 The authors have no financial interest in the subject matter of this poster.
Eltutar, Kadir; Akcetin, Tulay A.; Ozcelik, N. Demet Istanbul Education and Research Hospital Department of Ophthalmology The authors state that they have.
Ruth Lapid-Gortzak MD PhD 1,2, Jan Willem van der Linden BOpt 2, and Ivanka J. van der Meulen MD 1,2 1 Department of Ophthalmology, Academic Medical Center,
Multifocal and Toric IOLs: An Update on the Resident Experience M. Allison Roensch, MD, Preston H. Blomquist, MD, Nalini K Aggarwal, MD, Justin W. Charton,
Long-term Follow-up for Intrastromal Cornea Ring Segments in Early to Severe Keratoconic Patients Omer Trivizki 1,Eliya Levinger 1,2, Irit Bareqet 2, Ami.
Clinical evaluation of foldable acrylic phakic IOL (fP) implantation ASCRS, San Diego, 2011 A.John Kanellopoulos, MD Professor NYU Medical School, NY Director,
1 Clinical Performance of the Crystalens® AO Guy M. Kezirian, MD, FACS.
Retrospective Comparison of 3177 Eyes Implanted with Presbyopic IOLs Carlos Buznego MD Elizabeth A. Davis MD, FACS Guy M. Kezirian MD, FACS William B.
M. Allison Roensch, MD, Preston H. Blomquist, MD, Nalini K Aggarwal, MD, James P. McCulley, MD Department of Ophthalmology University of Texas Southwestern.
Justin Charton, MD, Preston H. Blomquist, MD, Nalini K. Aggarwal, MD, James P. McCulley, MD University of Texas Southwestern Department of Ophthalmology.
The Effect of the Restor Multifocal IOL on Frequency Doubling Perimetry Elizabeth Yeu, MD1, Elizabeth Woznak, BS2, Nicole Kesten, BS2, Steven VL Brown,
Repeatability of Anterior and Posterior Corneal Higher- Order Aberrations in 4 mm, 6 mm and 8 mm diameters measured by Pentacam System Jadwiga Wojtowicz.
Evaluation of Corneal Parameters and Spherical Aberration After DSAEK Measured with Pentacam System Orkun Muftuoglu, Pawan Prasher, R. Wayne Bowman, Steven.
Autologous serum eye drops in severe post-LASIK dry eye.
Blended vision after bilateral monofocal cataract surgery: an evaluation of spectacle independence and vision related quality of life Allison Landes, MD.
Phacoemulsification in eyes with previous anterior chamber phakic IOL surgery Walton Nosé, MD, PhD 1,2 Adriana dos Santos Forseto, MD 1 Mariana Ávila,
Change in Patient-Reported Outcomes and Visual Acuity After Bilateral Implantation of Apodized Diffractive +3.0 IOLs Stephen Lane, MD Consultant, Alcon.
Unilateral multifocal lens implantation in patients with a contralateral monofocal or phakic eye is a viable presbyopic correction option Robert J. Cionni,
Neeti Parikh, MD Fuxiang Zhang, MD Department of Ophthalmology Henry Ford Hospital A Comparison Of Patient Satisfaction With Modified Monovision Versus.
A Fellow Eye Comparison of Aberrations, Modulation Transfer Function and Contrast Sensitivity After AcrySof IQ and AcrySof Natural IOL Implantation. Mayank.
Evaluation of Zonal Equivalent Keratometry Readings After LASIK Timmy Kovoor, MD Orkun Muftuoglu, MD V.Vinod Mootha, MD Steven Verity, MD R. Wayne Bowman,
Prospective Study of Intrastromal Corneal Ring Segments for Keratoconus Scott X. Stevens, MD Bend Ophthalmology, LLC Author has no financial interest.
Astigmatism management with toric intraocular lenses in cataract patients Adriano Guarnieri 1-2, Luis W. Lu 3-4, Alfonso Arias- Puente INCIVI, Madrid,
Use of Multifocal IOLs in Patients with Age-Related Macular Degeneration Helga P. Sandoval, MD, MSCR 1 Reid B. Murphy, MD, 1 Luis E. Fernández de Castro,
P91: Clinical Performance of Phakic Angle-Supported Investigational IOL in Prospective Global Trials, ASCRS 2010, Boston P91: Clinical performance of phakic.
Clinical outcomes of Epi-LASIK : 1-Year-Long Results of Flap ON/OFF with Mitomycin-C ON/OFF Gil-Joong Yoon (MD/PhD) 1 Seong-Taeck Kim (MD) 2 Jae-Woong.
Effect of Aspherical Intraocular Lens on Blue-on-Yellow Perimetry  No eye had intraoperative complications. At 12 months after surgery, all the lenses.
Results of Collagen Crosslinking followed by posterior chamber toric implantable collamer lens implantation in patients with Keratoconus & High Myopia.
OHM Effect of low-to-moderate degrees of refractive astigmatism on Contrast sensitivity and Reading speed in pseudophakic eyes Shetal M. Raj, DO, MS, Abhay.
REFRACTIVE OUTCOMES WITH TORIC ICL IMPLANTS CHIEF AUTHOR: Dr. D.RAMAMURTHY CO – AUTHOR: Dr. R.CHITRA The authors have no financial interest in the subject.
Comparison of LASIK and Mitomycin-C Assisted LASEK for Correction of Refractive Errors After Cataract Surgery Dr. Nitin Balakrishnan, Crystal Vision Laser.
Adriana S. Forseto1, MD Walton Nosé1,2, MD
Binocular Defocus Curve of Apodized Diffractive Multifocal IOL in Asian-Indian Eyes Dr.A. Shetty; Dr. M. K. Kummelil; Dr. S.Nagappa Cataract and Refractive.
Faik Orucov*, MD, Sinan Goker*,MD, Abraham Solomon**, MD, Joseph Frucht-Pery**, MD *Refractive Surgery Department, ISTANBUL SURGERY HOSPITAL Istanbul,
AcrySof ® ReSTOR ® Aspheric IOL. Aspheric IOL AcrySof ® ReSTOR ® 2 AcrySof ® ReSTOR ® Aspheric IOL SN6AD3 Add Power: +4 D Spectacle Plane: 3.2 D Range:
Influence of IOL optic material on posterior capsule opacification and visual function Ken Hayashi, MD Hideyuki Hayashi, MD Hayashi Eye Hospital, Fukuoka,
S. Lee/M.Kim 2010 M. Kim 1, H. Lee 1, S. Lee 1,, S.D. Lee 1 1 ASA-Vision Clinics Seoul Comparative Analysis Preliminary Results of.
LogMAR-Analysis of multifocal intraocular lenses: Clinical performance A. Mannsfeld, I.-J. Limberger, A. Ehmer, M.P. Holzer, G. U.Auffarth International.
Wavefront-guided Ablation Retreatment in Myopic Eyes Engy M Mohamed MD, Orkun Muftuoglu MD, R.Wayne Bowman MD, V. Vinod Mootha MD, H. Dwight Cavanagh MD,PhD,
Comparison of visual function following piggyback implantation of Acrysof ReSTOR intraocular lenses with Tecnis multifocal ZM900 intraocular lenses. Rodrigo.
Investigation of Multifocal Toric IOLs to Compensate for Corneal Astigmatism and to Provide Near, Intermediate, and Distance Vision José L. Rincón, MD.
Preliminary Results after Cataract Surgery with the Aspheric Acrysof ReSTOR IOL to Correct Presbyopia Meeting of the ASCRS Chicago 8-10 February 2007 R.M.M.A.
F.I. Camesasca, MD Zeiss Invent ZO Aspheric IOL: Long-Term Results of Refractive and Aberrometric Analysis F. I. Camesasca* P. Vinciguerra.
Dissatisfication After Multifocal Intraocular Lens Implantation in Taiwan Yu Wei Lin, MD (Presenting Author); Ching-Ju Hsieh; Lin-Chung Woung The authors.
Liquifaction Method and Extent of Posterior Capsule Opacification: Two-Year Follow-up Marie Kalfertova, Mariya Burova, Pavel Rozsival, Nada Jiraskova Nada.
FreeVis LASIK Zentrum Universitätsklinikum Mannheim
Postoperative Refraction and Patient Satisfaction after Bilateral Implantation of Presbyopia-Correcting Intraocular Lenses Robert Cionni, MD Financial.
Hayashi Eye Hospital, Fukuoka, Japan
Wavefront Optimized Retreatment after Prior Wavefront
Corneal High-Order Aberrations in Keratoconus
Consultant for Alcon. AMO, Bausch and Lomb
Early Experience with Descemet’s Stripping Automated Endothelial Keratoplasty Combined with Phacoemulsification: Clinical and Refractive Outcome University.
Sarosh A. Janjua MD1, Sandra L. Cremers MD FACS1
Thomas Kohnen, MD Department of Ophthalmology
Long term Results of Endothelial Keratoplasty in patients with failed penetrating Keratoplasty Maoz D. Amiran, MD, Raneen Shehadeh-Mashor, MD, Marie Eve.
The authors have no financial interest to disclosure
David T. Vroman, MD Assistant Professor of Ophthalmology
Kellan Tetraflex KH3500 Accommodative IOLs vs. Acri
The authors have no financial interest
Visual Outcomes and Satisfaction with Toric IOL Versus Monofocal IOL
Comparative Global Literature Review of Visual and Optical Quality of Refractive, Diffractive, and Hybrid IOL Designs James P. McCulley, MD Department.
Consultant Alcon Laboratories, Fort Worth
Michael Goodman, Alexandra Paul and Andrew Hsu
Presentation transcript:

LONG TERM OUTCOMES OF RESTOR IOL IMPLANTATION Lori Dao, Orkun Muftuoglu, V. Vinod Mootha, Steven M. Verity, R. Wayne Bowman, H. Dwight Cavanagh, James P. McCulley University of Texas Southwestern Medical Center Department of Ophthalmology Dallas, Texas Drs. Bowman, Verity, and McCulley receive consultant reimbursement from Alcon. Dr. Cavanagh receives research reimbursements from Ciba and Menion. None of the authors have financial interest in the subject matter of this poster. Supported in part by an unrestricted research grant from Research to Prevent Blindness, Inc., New York, New York.

INTRODUCTION Multifocal IOLs were introduced to restore the distance and near without any correction. Multifocal IOLs were introduced to restore the distance and near without any correction. Early models provided limited near correction and/or often related with glare and halos Early models provided limited near correction and/or often related with glare and halos Recent models are reported to provide more powerful near correction with less unwanted visual phenomena. Recent models are reported to provide more powerful near correction with less unwanted visual phenomena. The AcrySof apodized diffractive IOL (Alcon Laboratories Inc., Fort Worth, Texas) The AcrySof apodized diffractive IOL (Alcon Laboratories Inc., Fort Worth, Texas) Good biocompatability with high refractive index, Flexibility Good biocompatability with high refractive index, Flexibility The diffractive steps gradually reduce in height and spacing from the lens center to the edge The diffractive steps gradually reduce in height and spacing from the lens center to the edge Add power of +4.0 Diopters (D). Add power of +4.0 Diopters (D).

PURPOSE To evaluate the long-term visual and refractive outcomes of apodized diffractive multifocal IOL (Restor) implantation.

METHODS Retrospective Retrospective IRB approval UT Southwestern Medical Center IRB approval UT Southwestern Medical Center Declaration of Helsinki guidelines for Declaration of Helsinki guidelines for HIPAA HIPAA Retrospective design, no consent form for the inclusion to the study. Retrospective design, no consent form for the inclusion to the study. 322 eyes of 176 consecutive patients underwent phacoemulsification surgery with AcrySof Restor IOL implantation between December 2005 and June 2008 at the University of Texas Southwestern Medical Center. 322 eyes of 176 consecutive patients underwent phacoemulsification surgery with AcrySof Restor IOL implantation between December 2005 and June 2008 at the University of Texas Southwestern Medical Center. 53 eyes of 34 patient who had refractive surgery prior to Restor IOL implantation were excluded 53 eyes of 34 patient who had refractive surgery prior to Restor IOL implantation were excluded 269 eyes of 151 patients included in the study 269 eyes of 151 patients included in the study 2 eyes of 1 patient with Restor explanted due to glare. 1 patient unhappy with Restor chose monofocal for fellow eye. 2 eyes of 1 patient with Restor explanted due to glare. 1 patient unhappy with Restor chose monofocal for fellow eye. The preoperative and follow-ups 1, 6 months, and the last follow-up after Restor IOL implantation were evaluated for this study The preoperative and follow-ups 1, 6 months, and the last follow-up after Restor IOL implantation were evaluated for this study 14 eyes of 8 patients lost to follow-up 6 months after Restor IOL impantation. 14 eyes of 8 patients lost to follow-up 6 months after Restor IOL impantation.

Groups Number of eyes Number of patients All Restor only15194 LRI3523 LRI/LASIK2214 LASIK6145

1 month: p = month: p = 0.46 Last f/u: p = 0.30, P = One-way ANOVA

1 month: p = month: p = 0.09 Last f/u: p = 0.13, P = One-way ANOVA

Spherical Equivalent and Cylinder

CONCURRENT UCVA / UCNVA for Restor and Restor + LRI

Restor and Restor+LRI Groups UCVAUCNVA

Nd:YAG Comparison of vision and refraction of eyes that underwent Nd:YAG capsulotomy and those that did not at last follow-up. YAG (-)YAG (+)P* VISUAL ACUITY (logmar) UCVA0.10 ± ± BSCVA0.03 ± ± UCNVA0.10 ± ± REFRACTION (D) S-0.03 ± ± C0.65 ± ± SE0.10 ± ± *Student’s t-test

Discussion Although Restor alone and Restor+LRI groups significantly had better UCVA at 1 month, there was no significant difference in UCVA between groups at last follow-up. Although Restor alone and Restor+LRI groups significantly had better UCVA at 1 month, there was no significant difference in UCVA between groups at last follow-up. No statistically significant difference in BCVA and UCNVA between groups at 1 mos, 6 mos or last f/u. No statistically significant difference in BCVA and UCNVA between groups at 1 mos, 6 mos or last f/u. UCNVA and UCVA were stable for the duration of follow-up in Restor alone and Restor+LRI groups. UCNVA and UCVA were stable for the duration of follow-up in Restor alone and Restor+LRI groups. Spherical equivalent and cylinder were stable for all groups Spherical equivalent and cylinder were stable for all groups 69% of eyes in Restor alone and Restor+LRI groups had concurrent 20/25 or better UCVA and J1 or better UCNVA at last follow-up 69% of eyes in Restor alone and Restor+LRI groups had concurrent 20/25 or better UCVA and J1 or better UCNVA at last follow-up